Diisopropylethylamine → HCID 23146362, compound
Reaction equation
[NH:1]1[CH2:6][CH2:5][CH2:4][CH2:3][CH:2]1[CH2:7][C:8]1[N:16]=[C:11]2[CH2:12][CH2:13][CH2:14][CH2:15][N:10]2[N:9]=1.N1CCCCC1CC1N=C2C=CC=CN2N=1.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C(N(CC)C(C)C)(C)C.[F:66][C:67]1[CH:72]=[CH:71][C:70]([C:73]2[S:77][C:76]([CH3:78])=[N:75][C:74]=2[C:79](O)=[O:80])=[CH:69][CH:68]=1>CN(C=O)C>[F:66][C:67]1[CH:68]=[CH:69][C:70]([C:73]2[S:77][C:76]([CH3:78])=[N:75][C:74]=2[C:79]([N:1]2[CH2:6][CH2:5][CH2:4][CH2:3][CH:2]2[CH2:7][C:8]2[N:16]=[C:11]3[CH:12]=[CH:13][CH:14]=[CH:15][N:10]3[N:9]=2)=[O:80])=[CH:71][CH:72]=1Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 1
Procedure
The mixture of 2-piperidin-2-ylmethyl-5,6,7,8-tetrahydro-[1,2,4]-triazolo[1,5-a]pyridine and 2-piperidin-2-ylmethyl-[1,2,4]-triazolo[1,5-a]pyridine, D34 (0.220 g) was treated with HATU (0.380 g), N,N-diisopropylethylamine (1.0 ml) and 5-(4-fluorophenyl)-2-methylthiazole-4-carboxylic acid (0.240 g) in dry DMF, according to the procedure described in Example 60. The crude product was chromatographed (silica gel, 4% methanol-diethyl ether) to afford 1-[5-(4-fluoro-phenyl)-2-methylthiazol-4-yl]-1-(2-[1,2,4]-triazolo[1,5-a]pyridin-2-ylmethylpiperidin-1-yl)-methanone as a colourless foam (0.070 g) (Mass spectrum (API+): found 436 (MH+): C23H22FN5OS requires 435). Continued elution (10% methanol-diethyl ether) afforded 1-[5-(4-fluoro-phenyl)-2-methyl-thiazol-4-yl]-1-[2-(5,6,7,8-tetrahydro-[1,2,4]-triazolo[1,5-a]pyridin-2-ylmethyl)-piperidin-1-yl]-methanone as a colourless foam (0.230 g) (Mass spectrum (API+): found 440 (MH+): C23H26FN5OS requires 439).
Workup
- customThe crude product was chromatographed (silica gel, 4% methanol-diethyl ether)
Sources & evidence
- ORD record
- ord-37316e0753524752a44717ac5472bb53
- Source dataset
- uspto-grants-2011_02
- Patent number
- US07893090B2
Reaction notes
Loading…